InMode (INMD) Capital Expenditures Growth (1y) (2019 - 2026)
InMode (INMD) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | 15.89% |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | 106.98% |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | -11.95% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | -47.73% |
| 10 | InMode | 981,130.50 | -479.15 Mn | 61.55 Mn | -102.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -102.35% |
| Dec 31, 2025 | -128.21% |
| Sep 30, 2025 | -74.03% |
| Jun 30, 2025 | 10.98% |
| Mar 31, 2025 | 24.11% |
| Dec 31, 2024 | -1,014.29% |
| Sep 30, 2024 | 48.32% |
| Jun 30, 2024 | -26.80% |
| Mar 31, 2024 | 67.16% |
| Dec 31, 2023 | 93.60% |
| Sep 30, 2023 | 61.50% |
| Jun 30, 2023 | 65.42% |
| Mar 31, 2023 | -14.05% |
| Dec 31, 2022 | -80.22% |
| Sep 30, 2022 | -52.36% |
| Jun 30, 2022 | -65.98% |
| Mar 31, 2022 | -81.21% |
| Dec 31, 2021 | -420.00% |
| Sep 30, 2021 | -146.60% |
| Jun 30, 2021 | -49.56% |